Harbor Investment Advisory’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.62K | Hold |
150
| – | – | ﹤0.01% | 889 |
|
|
2025
Q1 | $9.52K | Hold |
150
| – | – | ﹤0.01% | 876 |
|
|
2024
Q4 | $9.98K | Hold |
150
| – | – | ﹤0.01% | 863 |
|
|
2024
Q3 | $10.5K | Hold |
150
| – | – | ﹤0.01% | 854 |
|
|
2024
Q2 | $9.72K | Hold |
150
| – | – | ﹤0.01% | 861 |
|
|
2024
Q1 | $9.71K | Hold |
150
| – | – | ﹤0.01% | 859 |
|
|
2023
Q4 | $9.88K | Hold |
150
| – | – | ﹤0.01% | 832 |
|
|
2023
Q3 | $8.56K | Hold |
150
| – | – | ﹤0.01% | 841 |
|
|
2023
Q2 | $9.19K | Hold |
150
| – | – | ﹤0.01% | 1039 |
|
|
2023
Q1 | $9.42K | Sell |
150
-30
| -17% | -$1.88K | ﹤0.01% | 1041 |
|
|
2022
Q4 | $11.4K | Hold |
180
| – | – | ﹤0.01% | 996 |
|
|
2022
Q3 | $11K | Hold |
180
| – | – | ﹤0.01% | 1025 |
|
|
2022
Q2 | $10K | Hold |
180
| – | – | ﹤0.01% | 1031 |
|
|
2022
Q1 | $11K | Hold |
180
| – | – | ﹤0.01% | 1037 |
|
|
2021
Q4 | $13K | Hold |
180
| – | – | ﹤0.01% | 1013 |
|
|
2021
Q3 | $13K | Hold |
180
| – | – | ﹤0.01% | 1012 |
|
|
2021
Q2 | $14K | Hold |
180
| – | – | ﹤0.01% | 956 |
|
|
2021
Q1 | $13K | Sell |
180
-20
| -10% | -$1.44K | ﹤0.01% | 936 |
|
|
2020
Q4 | $14K | Hold |
200
| – | – | ﹤0.01% | 873 |
|
|
2020
Q3 | $11K | Hold |
200
| – | – | ﹤0.01% | 832 |
|
|
2020
Q2 | $12K | Hold |
200
| – | – | ﹤0.01% | 742 |
|
|
2020
Q1 | $9K | Hold |
200
| – | – | ﹤0.01% | 766 |
|
|
2019
Q4 | $11K | Buy |
+200
| New | +$11K | ﹤0.01% | 614 |
|